EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Peptide‐Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives

Christian S Carnero Canales iD, Ana Clara Lunardi Yagi iD, Túlio Custódio Reis iD, Jessica Ingrid Cazorla iD, Jade Rojas Villar, Marcia A Graminha, Roxana Yesenia Pastrana Alta, Fernando Rogério Pavan iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.70493 ↗

At a glance

Übersichtsarbeit in ChemMedChem, 2026. Written by Christian S Carnero Canales and 7 co-authors. Institution: BIOMET Laboratorio de Química Bioinorgánica en Medicina, Medioambiente y Tecnología, Facultad de Ciencias de la Universidad Nacional de Ingeniería, L…. Major MEDLINE topics: Leishmaniasis, Malaria, Peptides, Nanoparticles. 256 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Program for Scientific Research and Advanced Studies, Interinstitutional Alliances for Doctoral Programs, Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Malaria and leishmaniasis continue to impose a substantial health burden, while current therapeutic and diagnostic strategies remain limited by toxicity, prolonged regimens, drug resistance, and restricted field applicability. This review examines recent advances in peptide‐enabled nanoplatforms for both diseases, with emphasis on intracellular targeting, drug delivery, and diagnostic innovation. Antimicrobial peptides, cell‐penetrating peptides, peptoids, mimotopes, and peptide‐functionalized nanocarriers have been explored to improve parasite targeting, intracellular delivery, pharmacokinetics, and antiparasitic efficacy. In parallel, peptide‐ and aptamer‐based nanosensors have expanded the detection of clinically relevant biomarkers, including HRP2, pLDH, GP63, KMP‐11, and kDNA, highlighting their potential for sensitive and modular diagnostics. Despite these advances, translation remains constrained by limited in vivo validation, insufficient pharmacokinetic standardization, incomplete toxicity profiling, poor batch reproducibility, protein corona‐associated variability, and scarce validation under field‐relevant conditions. Peptide‐enabled nanoplatforms are therefore most likely to succeed when aligned with stage‐specific parasite biology, realistic host cell‐targeting requirements, and scalable implementation pathways in endemic settings.

Subjects

MeSH terms (MEDLINE)

LeishmaniasisMalariaPeptidesNanoparticlesHumansAnimalsLeishmaniaCell-Penetrating PeptidesDrug Delivery Systems

Author keywords

antimicrobial peptidescell‐penetrating peptidesleishmaniasismalariananocarriersnanoplatforms

Substances

PeptidesCell-Penetrating Peptides

Authors and institutions

  • BIOMET Laboratorio de Química Bioinorgánica en Medicina, Medioambiente y Tecnología, Facultad de Ciencias de la Universidad Nacional de Ingeniería, Lima, Peru.
  • School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
  • General humanidades, Universidad Continental (UC), Arequipa, Perú.
  • School of Pharmacy, Biochemistry and Biotechnology, Universidad Católica Santa María (UCSM), Arequipa, Perú.

ORCID profiles: Christian S Carnero Canales, Ana Clara Lunardi Yagi, Túlio Custódio Reis, Jessica Ingrid Cazorla, Fernando Rogério Pavan

Funding

  • National Program for Scientific Research and Advanced Studies
  • Interinstitutional Alliances for Doctoral Programs
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Cite

APA

Carnero Canales, C. S., Lunardi Yagi, A. C., Reis, T. C., Cazorla, J. I., Rojas Villar, J., Graminha, M. A., Pastrana Alta, R. Y., & Pavan, F. R. (2026). Peptide‐Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives. ChemMedChem. https://doi.org/10.1002/cmdc.70493

Vancouver

Carnero Canales CS, Lunardi Yagi AC, Reis TC, Cazorla JI, Rojas Villar J, Graminha MA, et al. Peptide‐Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives. ChemMedChem. 2026. doi:10.1002/cmdc.70493

BibTeX
@article{CarneroCanales2026,
  author = {Carnero Canales, Christian S and Lunardi Yagi, Ana Clara and Reis, Túlio Custódio and Cazorla, Jessica Ingrid and Rojas Villar, Jade and Graminha, Marcia A and Pastrana Alta, Roxana Yesenia and Pavan, Fernando Rogério},
  title = {Peptide‐Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.70493}
}
Start for free →